Literature DB >> 2862420

Creutzfeldt-Jakob disease after administration of human growth hormone.

J Powell-Jackson, R O Weller, P Kennedy, M A Preece, E M Whitcombe, J Newsom-Davis.   

Abstract

A 2-year-old girl had a craniopharyngioma removed in 1964. She received human growth hormone (HGH) twice a week from July, 1972, until July, 1976. In March, 1984, a subacute dementing illness developed with neurological signs that included pronounced cerebellar ataxia. A clinical diagnosis of Creutzfeldt-Jakob disease (CJD) was made. The patient died in February, 1985. Necropsy revealed a spongiform encephalopathy compatible with the transmissible form of CJD. HGH administration may be implicated in the transmission of the disease in this case.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862420     DOI: 10.1016/s0140-6736(85)90292-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

1.  The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease.

Authors:  R J Cordery; K Alner; L Cipolotti; M Ron; A Kennedy; J Collinge; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

2.  Previous human GH treatment and leukemia.

Authors:  A Sartorio; A Conti; G Faglia; G Guzzaloni; F Morabito
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

Review 3.  Growth hormone therapy in Canada: end of one era and beginning of another.

Authors:  H J Dean; H G Friesen
Journal:  CMAJ       Date:  1986-08-15       Impact factor: 8.262

4.  Human growth hormone treatment and Creutzfeldt-Jakob disease.

Authors:  A Sartorio; M Arosio; G Faglia; M Resentini; F Morabito
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

5.  Growth hormone 1985.

Authors:  R D Milner
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

6.  Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors.

Authors:  R Harries-Jones; R Knight; R G Will; S Cousens; P G Smith; W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

7.  Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Rebecca Rosenke; James F Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

8.  Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

Authors:  R J Cordery; M Hall; L Cipolotti; S Al-Sarraj; D G O'Donovan; L Davidson; P Adlard; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Growth of children with Langerhans cell histiocytosis.

Authors:  A C van den Hoek; A Karstens; R M Egeler; K Hählen
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

10.  A further British case of growth hormone induced Creutzfeldt-Jakob disease.

Authors:  C J Ellis; H Katifi; R O Weller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.